Relationship between plasma concentration of direct oral anticoagulants and clinical prognosis

Relationship between plasma concentration of direct oral anticoagulants and clinical prognosis - Relationship between plasma concentration of direct oral anticoagulants and clinical prognosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043250

Enrollment

300

Registered

2021-06-01

Start date

2021-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

To measure plasma concentration of direct oral anti-coagulants Relationship between plasma concentration of direct oral anti-coagulants and clinical prognosis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients taking any of the DOACs, apixaban, dabigatran, edoxaban, or rivaroxaban were included. People who have agreed to participate in the research.

Exclusion criteria

Exclusion criteria: People who have not agreed to participate in the research.

Design outcomes

Primary

Measure	Time frame
Plasma concentration of direct oral anti-coagulants and clinical prognosis	—

Countries

Japan

Contacts

Public ContactYuichiro Maekawa

Hamamatsu University School of Medicine Internal Medicine III

rsato@hama-med.ac.jp0534352356

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026